Literature DB >> 7059971

Cloning and screening of sequences expressed in a mouse colon tumor.

L H Augenlicht, D Kobrin.   

Abstract

Polyadenylic acid-containing cytoplasmic RNA was isolated from a dimethylhydrazine-induced mouse transplantable colon carcinoma. Double-stranded complementary DNA synthesized using these molecules was inserted into the HindIII site of pBR322 using HindIII linkers, and the recombinant molecules were cloned in Escherichia coli. Clones were screened with labeled complementary DNA synthesized from the polyadenylic acid-containing cytoplasmic RNA of the tumor or normal mouse colon, liver, or kidney. Of 378 clones screened with the normal colon and tumor probes, seven showed major increases in abundance in the tumor tissue as compared to normal, and one showed a major decrease. Twenty-five other sequences were found which showed smaller increases and 22 showed smaller decreases. Of 373 clones screened with tumor, colon, liver, and kidney probes, 79% exhibited little evidence of tissue specificity in expression. The data for those sequences which do show tissue-specific regulation of expression suggest that the tumor continues to express sequences characteristic of the colon but also shows a loss, or decrease, in other gene products, most of which (19 of 25) are characteristic of the colon. Finally, nine of 10 sequences which increase from low abundance in the normal colon to high abundance in the tumor are found at a moderate to high level in the liver and kidney. On the other hand, 23 of 36 sequences which show more modest increases in the tumor as compared to normal are scarce or absent in the liver and kidney.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059971

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Carbon Substrates: A Stable Foundation for Biomolecular Arrays.

Authors:  Matthew R Lockett; Lloyd M Smith
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2015-06-03       Impact factor: 10.745

Review 2.  Coming of age: ten years of next-generation sequencing technologies.

Authors:  Sara Goodwin; John D McPherson; W Richard McCombie
Journal:  Nat Rev Genet       Date:  2016-05-17       Impact factor: 53.242

3.  Expression of a mouse long terminal repeat is cell cycle-linked.

Authors:  L H Augenlicht; H Halsey
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Cell-cycle-specific cDNAs from mammalian cells temperature sensitive for growth.

Authors:  R R Hirschhorn; P Aller; Z A Yuan; C W Gibson; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

Review 5.  Targeted protein-omic methods are bridging the gap between proteomic and hypothesis-driven protein analysis approaches.

Authors:  Ronald J Hause; Hyung-Do Kim; Kin K Leung; Richard Baker Jones
Journal:  Expert Rev Proteomics       Date:  2011-10       Impact factor: 3.940

6.  Cloning of sequences expressed specifically in tumors of rat.

Authors:  M Yamamoto; Y Maehara; K Takahashi; H Endo
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

7.  Cloning of mRNA sequences from the human colon: preliminary characterisation of defined mRNAs in normal and neoplastic tissues.

Authors:  R A Bartsch; C Joannou; I C Talbot; D S Bailey
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

Review 8.  Microarrays for identifying binding sites and probing structure of RNAs.

Authors:  Ryszard Kierzek; Douglas H Turner; Elzbieta Kierzek
Journal:  Nucleic Acids Res       Date:  2014-12-12       Impact factor: 16.971

9.  Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumour progression and metastasis in colorectal cancer.

Authors:  P Elvin; I B Kerr; C S McArdle; G D Birnie
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

10.  Microarray-based ultra-high resolution discovery of genomic deletion mutations.

Authors:  Eric J Belfield; Carly Brown; Xiangchao Gan; Caifu Jiang; Dilair Baban; Aziz Mithani; Richard Mott; Jiannis Ragoussis; Nicholas P Harberd
Journal:  BMC Genomics       Date:  2014-03-22       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.